Cargando…
Esters of levonorgestrel and etonogestrel intended as single, subcutaneous-injection, long-lasting contraceptives
An effort with the goal of discovering single-dose, long-lasting (>6 months) injectable contraceptives began using levonorgestrel (LNG)-17-β esters linked to a sulfonamide function purposed as human carbonic anhydrase II (hCA 2) ligands. One single analog from this first series showed noticeably...
Autores principales: | Meece, Frederick A., Ahmed, Gulzar, Nair, Hareesh, Santhamma, Bindu, Tekmal, Rajeshwar R., Zhao, Chumang, Pollok, Nicole E., Lara, Julia, Shaked, Ze'ev, Nickisch, Klaus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137153/ https://www.ncbi.nlm.nih.gov/pubmed/30086356 http://dx.doi.org/10.1016/j.steroids.2018.07.010 |
Ejemplares similares
-
BU-32: a novel proteasome inhibitor for breast cancer
por: Agyin, Joseph K, et al.
Publicado: (2009) -
A three-year longitudinal evaluation of the forearm bone density of users of etonogestrel- and levonorgestrel-releasing contraceptive implants
por: Monteiro-Dantas, Cecilia, et al.
Publicado: (2007) -
Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant
por: Ali, Moazzam, et al.
Publicado: (2016) -
Early removal of etonogestrel subcutaneous contraceptive implant at a community health centre in Pretoria
por: Moeti, Dikonketjo M.P., et al.
Publicado: (2022) -
Effects of Combination of Estradiol with Selective Progesterone Receptor Modulators (SPRMs) on Human Breast Cancer Cells In Vitro and In Vivo
por: Nair, Hareesh B., et al.
Publicado: (2016)